EVENTIDE ASSET MANAGEMENT, LLC

Position in PCVX — Vaxcyte, Inc.

CIK 1442891 Boston, MA

Position in PCVX

as of Jun 30, 2026 · filed Aug 14, 2026 Compact

Position Value

$80,232,130

+$372,022 QoQ

Shares Held

1,380,219

+0.4% QoQ

Ownership

0.928%

of shares outstanding

% of Portfolio

1.07%

of 13F equity value

Holder Rank

#22

of 325 holders

Holding Since

Sep 2023

12 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Jun 30, 2026

EVENTIDE ASSET MANAGEMENT, LLC holds $1,774,593,873 across 55 Biotechnology names. PCVX ranks #4 (4.5% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	MIRM	Mirum Pharmaceuticals, Inc.	1,248,389	$146,148,900
2	ARGX	Argenx SE	125,668	$116,591,000
3	SRRK	Scholar Rock Holding Corp	2,111,410	$116,127,550
4	PCVX	Vaxcyte, Inc. This page	1,380,219	$80,232,130
5	AXSM	Axsome Therapeutics, Inc.	316,820	$77,548,031
6	RPRX	Royalty Pharma plc	1,380,261	$77,391,234
7	INSM	INSMED Inc	583,665	$62,230,362
8	BLTE	Belite Bio, Inc	390,829	$60,181,803

12 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$80,232,130	1,380,219	+0.4%	Shares	Sole	2026-08-14
2026-03-31	$79,860,108	1,374,292	+49.8%	Shares	Sole	2026-05-15
2025-12-31	$42,315,686	917,115	+141.8%	Shares	Sole	2026-02-13
2025-09-30	$13,663,466	379,330	-55.3%	Shares	Sole	2025-11-14
2025-06-30	$27,573,063	848,141	+80.4%	Shares	Sole	2025-08-14
2025-03-31	$17,755,884	470,230	+22.6%	Shares	Sole	2025-05-15
2024-12-31	$31,389,544	383,454	0.0%	Shares	Sole	2025-02-14
2024-09-30	$43,817,288	383,454	-48.1%	Shares	Sole	2024-11-14
2024-06-30	$55,813,443	739,153	+12.5%	Shares	Sole	2024-08-13
2024-03-31	$44,893,741	657,206	+8.2%	Shares	Sole	2024-05-15
2023-12-31	$38,132,536	607,206	+54.5%	Shares	Sole	2024-02-20
2023-09-30	$20,035,140	393,000	—	Shares	Sole	2023-11-14
No filing history on record for this holder in this stock.